Related references
Note: Only part of the references are listed.Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
H. J. Close et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2020)
Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro
Yoshitaka Tanaka et al.
PLOS ONE (2019)
A gene expression-based study on immune cell subtypes and glioma prognosis
Qiu-Yue Zhong et al.
BMC CANCER (2019)
Autocrine TGFβ Is a Survival Factor for Monocytes and Drives Immunosuppressive Lineage Commitment
Alba Gonzalez-Junca et al.
CANCER IMMUNOLOGY RESEARCH (2019)
General structural features that regulate integrin affinity revealed by atypical αVβ8
Jianchuan Wang et al.
NATURE COMMUNICATIONS (2019)
A novel immature natural killer cell subpopulation predicts relapse after cord blood transplantation
Li Li et al.
BLOOD ADVANCES (2019)
Metabolic heterogeneity and plasticity of glioma stem cells in a mouse glioblastoma model
Shunsuke Shibao et al.
NEURO-ONCOLOGY (2018)
Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering
May Daher et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Differential Expression and Clinical Significance of Transforming Growth Factor-Beta Isoforms in GBM Tumors
Laurent-Olivier Roy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes
Konrad Gabrusiewicz et al.
ONCOIMMUNOLOGY (2018)
TGF-β in T Cell Biology: Implications for Cancer Immunotherapy
Amina Dahmani et al.
CANCERS (2018)
NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma
Tobias Weiss et al.
CANCER RESEARCH (2018)
The CD9, CD81, and CD151 EC2 domains bind to the classical RGD-binding site of integrin αvβ3
Jessica Yu et al.
BIOCHEMICAL JOURNAL (2017)
Biomarker and Histopathology Evaluation of Patients with Recurrent Glioblastoma Treated with Galunisertib, Lomustine, or the Combination of Galunisertib and Lomustine
David Capper et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Immune microenvironment of gliomas
Anna Gieryng et al.
LABORATORY INVESTIGATION (2017)
Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy
Xiaoyang Lan et al.
NATURE (2017)
Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
Spyros Darmanis et al.
CELL REPORTS (2017)
TGFβ Signaling Intersects with CD103 Integrin Signaling to Promote T-Lymphocyte Accumulation and Antitumor Activity in the Lung Tumor Microenvironment
Marie Boutet et al.
CANCER RESEARCH (2016)
Cytotoxic activity of allogeneic natural killer cells on U251 glioma cells in vitro
Meng Guo et al.
MOLECULAR MEDICINE REPORTS (2016)
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Alba A. Brandes et al.
NEURO-ONCOLOGY (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
TGF-β inhibits the activation and functions of NK cells by repressing the mTOR pathway
Sebastien Viel et al.
SCIENCE SIGNALING (2016)
αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression
Anindita Dutta et al.
BIOCHEMICAL JOURNAL (2015)
Immunosuppressive mechanisms in glioblastoma
Edjah K. Nduom et al.
NEURO-ONCOLOGY (2015)
Transforming growth factor-β pathway activity in glioblastoma
Karl Frei et al.
ONCOTARGET (2015)
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
Katayoun Rezvani et al.
FRONTIERS IN IMMUNOLOGY (2015)
Pathological features of highly invasive glioma stem cells in a mouse xenograft model
Hirokazu Sadahiro et al.
BRAIN TUMOR PATHOLOGY (2014)
Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
Roger Stupp et al.
LANCET ONCOLOGY (2014)
Integrin control of the transforming growth factor-β pathway in glioblastoma
Patrick Roth et al.
BRAIN (2013)
Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level
Justyna Kmiecik et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity
Nina Shah et al.
PLOS ONE (2013)
aV integrins and TGF-ß-induced EMT: a circle of regulation
Fahmy A. Mamuya et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
The Cancer Stem Cell Subtype Determines Immune Infiltration of Glioblastoma
Christoph P. Beier et al.
STEM CELLS AND DEVELOPMENT (2012)
Blockade of TGF-β Signaling by the TGFβR-I Kinase Inhibitor LY2109761 Enhances Radiation Response and Prolongs Survival in Glioblastoma
Mengxian Zhang et al.
CANCER RESEARCH (2011)
Roles of matrix metalloproteinases in cancer progression and their pharmacological targeting
Chrisostomi Gialeli et al.
FEBS JOURNAL (2011)
Activating Signals Dominate Inhibitory Signals in CD137L/IL-15 Activated Natural Killer Cells
Hua Zhang et al.
JOURNAL OF IMMUNOTHERAPY (2011)
Immune Infiltration of Spontaneous Mouse Astrocytomas Is Dominated by Immunosuppressive Cells from Early Stages of Tumor Development
Nhu Nam Tran Thang et al.
CANCER RESEARCH (2010)
Transcriptional Profiles of CD133(+) and CD133(-) Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin
Claudio Lottaz et al.
CANCER RESEARCH (2010)
Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
Kai Kessenbrock et al.
CELL (2010)
Transforming growth factor-β1 induces matrix metalloproteinase-9 and cell migration in astrocytes: roles of ROS-dependent ERK- and JNK-NF-κB pathways
Hsi-Lung Hsieh et al.
JOURNAL OF NEUROINFLAMMATION (2010)
Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens
Steven M. Pollard et al.
CELL STEM CELL (2009)
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2009)
'Yin-Yang' functions of transforming growth factor-β and T regulatory cells in immune regulation
Yisong Y. Wan et al.
IMMUNOLOGICAL REVIEWS (2007)
Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: Role of autophagic, cell death
Hong Jiang et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Lymphokine activated killer cells from umbilical cord blood show higher antitumor effect against anaplastic astrocytoma cell line (U87) and medulloblastoma cell line (TE671) than lymphokine activated killer cells from peripheral blood
SG Kang et al.
CHILDS NERVOUS SYSTEM (2004)
Integrin αvβ6-associated ERK2 mediates MMP-9 secretion in colon cancer cells
X Gu et al.
BRITISH JOURNAL OF CANCER (2002)
Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
A Cerwenka et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
αvβ6 integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes
GJ Thomas et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2001)
MT1-MMP initiates activation of pro-MMP-2 and integrin αvβ3 promotes maturation of MMP-2 in breast carcinoma cells
EI Deryugina et al.
EXPERIMENTAL CELL RESEARCH (2001)
An implantable guide-screw system for brain tumor studies in small animals
S Lal et al.
JOURNAL OF NEUROSURGERY (2000)
Share Paper
